{"nct_id":"NCT01933932","title":"Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2013-09-25","start_date_type":"ACTUAL","primary_completion_date":"2016-06-07","primary_completion_date_type":"ACTUAL","completion_date":"2025-12-31","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}